vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n (Alomone Labs)
Structured Review

Vendor Apc Cy7 Cd45 Ox 1 Bd Pe Cy7 Cd11b C Ox 42 Bd Fitc P2y12 N, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vendor apc cy7 cd45 ox 1 bd pe cy7 cd11b c ox 42 bd fitc p2y12 n/product/Alomone Labs
Average 90 stars, based on 10 article reviews
Images
1) Product Images from "Combination therapy with Treg and MSC enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy"
Article Title: Combination therapy with Treg and MSC enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy
Journal: Stem cells (Dayton, Ohio)
doi: 10.1002/stem.3320
Figure Legend Snippet: (A): Representative samples from both sham and CCI groups are shown. The single cell population was identified based on SSC and FSC. Live cells were identified as negative for the 7-AAD. Microglia were identified using a two-step method. First, CD11b/c+ cells (PE-Cy7) were selected to identify all myeloid cells. The CD11b/c+ cells were then gated on P2Y12 (FITC) and CD45 (APC-Cy7). Microglia were identified as triple positive cells. SSC, side scatter; FSC, forward scatter. (B): The multiple color flow cytometry panel used to identify and immunophenotype microglia and peripheral myeloid cells.
Techniques Used: Flow Cytometry
Figure Legend Snippet: Multicolor Flow Cytometry Microglia/Myeloid Cell Panel
Techniques Used: Flow Cytometry